CCKB receptor antagonist L365,260 potentiates the efficacy to and reverses chronic tolerance to electroacupuncture-induced analgesia in mice

New peptide in the vertebrate CNS reacting with antigastrin antibodies

J.J. Vanderhaeghen, J. C. SIGNEAU, W Gepts · Nature · 1975 · 759 citations

Life Sciences, Neurobiology, Neuroscience +14

Evidence for the Neuropeptide Cholecystokinin as an Antagonist of Opiate Analgesia

Patricia L. Faris, Barry R. Komisaruk, Linda R. Watkins et al. · Science · 1983 · 582 citations

Medicine, Neuroscience, Pharmacology +17

Potentiation of Opiate Analgesia and Apparent Reversal of Morphine Tolerance by Proglumide

L.R. Watkins, B. Kinscheck I, D.J. Mayer · Science · 1984 · 264 citations

Medicine, Pharmacology, Behavioral Pharmacology +10

Cholecystokinin octapeptide (CCK-8): Antagonism to electroacupuncture analgesia and a possible role in electroacupuncture tolerance

Ji‐Sheng Han, Xuan-Zhou Ding, S.G. Fan · Pain · 1986 · 137 citations

Medicine, Pharmacology, Neuroendocrinology +13

Increased release of immunoreactive cholecystokinin octapeptide by morphine and potentiation of μ-opioid analgesia by CCKB receptor antagonist L-365,260 in rat spinal cord

Yan Zhou, Yuhua Sun, Ji-Shen Han · European Journal of Pharmacology · 1993 · 107 citations

Medicine, Anesthesiology, Pharmacology +14